학술논문
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial
Document Type
Article
Author
Source
In: Journal of Global Antimicrobial Resistance . (Journal of Global Antimicrobial Resistance, March 2023, 32:44-47)
Subject
Language
English
ISSN
22137173
22137165
22137165